Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	Related Studies

Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma

This study has been completed.
Information provided by Corixa Corporation

Please refer to this study by its ClinicalTrials.gov identifier: NCT00022945

Locations


United States, Illinois
	Rush-Presbyterian-St. Lukes Medical Center
	Chicago, Illinois, United States, 60612

United States, New York
	Memorial Sloan-Kettering Cancer Center
	New York, New York, United States, 10021

United States, Pennsylvania
	Hospital of the University of Pennsylvania
	Philadelphia, Pennsylvania, United States, 19104

Sponsors and Collaborators

Corixa Corporation